uBriGene uVivo™ LVV at CAR-TCR Summit 2026

uBriGene Showcases uVivo™LVV at 11th CAR-TCR Summit 2026

uBriGene at ISSCR 2026 | circRNA-LNP iPSC Reprogramming

Meet uBriGene at ISSCR 2026: Advancing iPSC Reprogramming with circRNA-LNP Technology

uBriGene uVivo™ LVV Platform at ASGCT 2026

uBriGene Showcases uVivo™ LVV—An IND-Ready In Vivo CAR-T Platform—at ASGCT 2026 Annual Meeting in Boston

uBriGene Highlights Innovative Platforms at ISCT 2026

uBriGene to Present circRNA-LNP and Lentiviral Manufacturing Innovations at ISCT 2026 in Dublin

uBriGene At Advanced Therapies Week 2026 | CGT Innovation

uBriGene to Drive Innovation in Cell & Gene Therapy at Advanced Therapies Week 2026 in San Diego

uBriGene at JPM 2026 | Cell & Gene Therapy Innovation

Where Science Meets Strategy: uBriGene Engages Global Leaders at JPM Healthcare Conference 2026

Advancing Lentiviral Vector Manufacturing at ASH 2025

uBriGene to Present High-Yield cGMP Lentiviral Vector Manufacturing Process at the 67th ASH Annual Meeting 2025

TIL Manufacturing Innovation at the 7th TIL Therapies Summit

uBriGene Biosciences to Showcase End-to-End TIL Manufacturing Innovation at the 7th TIL Therapies Summit in Boston, MA

Connect with uBriGene at The Advanced Therapies USA 2025

Meet uBriGene in Philadelphia: Driving the Future of Cell and Gene Therapy at The Advanced Therapies Congress 2025

Showcasing LVV Turbo at CAR-TCR Summit 2025

From LVV Turbo to CAR-TCR Solutions: uBriGene to Showcase Innovation at CAR-TCR Summit 2025 in Boston